Clinical Trials · NCT07630454
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Yunlong Wang
- Enrollment
- 602
- Start date
- Aug 2026
- Locations
- 1 site, China
- Primary endpoint
- Number of Participants With Recurrence of atrial fibrillation, atrial flutter, or atrial tachycardia